AimA prospective, randomized multicenter study was conducted to assess toxicity and radioprotective effects of amifostine (EthyolŽ) in head and neck cancer radiotherapy. Assessed were also local control and overall survival.Material and methodsSixty-one patients (43 men and 18 women) from five institutions were randomly assigned to radiotherapy alone (28 patients) or radiotherapy + amifostine (33 patients). Amifostine was given at a dose of 150 mg/m2 15 min prior to each fraction of radiotherapy. Definite and postoperative radiotherapy were given at a total dose of at least 66 Gy (43 patients) or 56 Gy (18 patients), respectively. Acute radiation reactions were assessed using the EORTC/RTOG scale, weekly during radiotherapy, and within 2 we...
Purpose Controversy exists regarding whether or not amifostine might reduce the efficacy of cancer t...
Objectives: Experimental data suggest a dose-dependent efficacy of amifostine so that the low overal...
WOS: 000245195200018PubMed ID: 16395679Five pediatric patients with head and neck cancers were treat...
A prospective, randomized multicenter study was conducted to assess the value of amifostine (Ethyol®...
AimA prospective, randomized multicenter study was conducted to assess toxicity and radioprotective ...
A prospective, randomized multicenter study was conducted to assess the value of amifostine (Ethyol®...
Amifostine is the most clinical used chemical radioprotector, but its effect in patients treated wit...
Objective: We aimed to investigate the effect of amifostine on acute and late side effects, and its ...
BACKGROUND:Amifostine is the most clinical used chemical radioprotector, but its effect in patients ...
BACKGROUND. The main objective of this study was to investigate whether non-daily intravenous admini...
Background: Amifostine has a potential role for salivary gland protection in head and neck cancer pa...
Background: Amifostine is the most clinical used chemical radioprotector, but its effect in patients...
BACKGROUND. The main objective of this study was to investigate whether non-daily intravenous admini...
PurposeControversy exists regarding whether or not amifostine might reduce the efficacy of cancer tr...
Amaç: Bu çalışmada Amifostinin akut radyoterapi toksisitesi üzerine olan etkisi ve tolerabilitesinin...
Purpose Controversy exists regarding whether or not amifostine might reduce the efficacy of cancer t...
Objectives: Experimental data suggest a dose-dependent efficacy of amifostine so that the low overal...
WOS: 000245195200018PubMed ID: 16395679Five pediatric patients with head and neck cancers were treat...
A prospective, randomized multicenter study was conducted to assess the value of amifostine (Ethyol®...
AimA prospective, randomized multicenter study was conducted to assess toxicity and radioprotective ...
A prospective, randomized multicenter study was conducted to assess the value of amifostine (Ethyol®...
Amifostine is the most clinical used chemical radioprotector, but its effect in patients treated wit...
Objective: We aimed to investigate the effect of amifostine on acute and late side effects, and its ...
BACKGROUND:Amifostine is the most clinical used chemical radioprotector, but its effect in patients ...
BACKGROUND. The main objective of this study was to investigate whether non-daily intravenous admini...
Background: Amifostine has a potential role for salivary gland protection in head and neck cancer pa...
Background: Amifostine is the most clinical used chemical radioprotector, but its effect in patients...
BACKGROUND. The main objective of this study was to investigate whether non-daily intravenous admini...
PurposeControversy exists regarding whether or not amifostine might reduce the efficacy of cancer tr...
Amaç: Bu çalışmada Amifostinin akut radyoterapi toksisitesi üzerine olan etkisi ve tolerabilitesinin...
Purpose Controversy exists regarding whether or not amifostine might reduce the efficacy of cancer t...
Objectives: Experimental data suggest a dose-dependent efficacy of amifostine so that the low overal...
WOS: 000245195200018PubMed ID: 16395679Five pediatric patients with head and neck cancers were treat...